Skip to content

The latest company news, press releases, and resources about Servier and everything our company has to offer.

Advanced Search
  • servier logo
     
    03.01.2021
    Agios Submits Supplemental New Drug Application to FDA for TIBSOVO® (ivosidenib tablets) for Patients with Previously Treated IDH1-Mutant Cholangiocarcinoma
  • servier logo
     
    01.17.2021
    Agios Presents Final Data from Phase 3 ClarIDHy Study of TIBSOVO® (ivosidenib tablets) in Patients with Previously Treated IDH1-Mutant Cholangiocarcinoma
  • servier logo
     
    01.12.2021
    Taiho Oncology and Servier To Present Data on LONSURF® (trifluridine and tipiracil) at 2021 ASCO Gastrointestinal Cancers Symposium (ASCO GI)
  • servier logo
     
    12.22.2020
    Servier Announces a Collaboration to Explore Immune Checkpoint Signaling in Cancer
  • servier logo
     
    12.21.2020
    Servier and Celsius Therapeutics Announce Target Discovery Collaboration in Colorectal Cancer
Show 5102550100 per page
Media Contacts

Servier Media Relations
us2mediarelations@servier.com

Subscribe